---
title: "Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder), all indications: Indication questions"
description: "Indication questions on Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is the generic name of Trelegy Ellipta? What type of drug is Trelegy (ICS, LAMA, and LABA)? When was Trelegy Ellipta first approved in the US? 3 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/trelegy-ellipta/indication"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder), all indications: Indication questions

Manufacturer: GlaxoSmithKline  
Prescribing information: [Trelegy Ellipta](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF)  
Indication pages: [Chronic obstructive pulmonary disease](https://www.evicenter.com/medical-information/trelegy-ellipta--chronic-obstructive-pulmonary-disease)

## Drug names

<a id="trelegy-generic-name"></a>

### What is the generic name of Trelegy Ellipta?

> “TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol 
> inhalation powder), for oral inhalation use”

Source: [TRELEGY ELLIPTA: Prescribing information, page 1, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF#page=1)

<a id="trelegy-drug-class"></a>

### What type of drug is Trelegy (ICS, LAMA, and LABA)?

> “TRELEGY ELLIPTA is an inhalation powder drug product for delivery of a combination of 
> fluticasone furoate (an ICS), umeclidinium (an anticholinergic), and vilanterol (a LABA) to 
> patients by oral inhalation.”

Source: [TRELEGY ELLIPTA: Prescribing information, page 21, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF#page=21)

> “TRELEGY delivers an ICS, a LABA, and a LAMA in a single ELLIPTA inhaler.”

Source: [TRELEGY ELLIPTA: A COPD or Asthma Treatment, captured 2026-11-14](https://www.trelegyhcp.com/#:~:text=TRELEGY%20delivers%20an%20ICS%2C%20a,in%20a%20single%20ELLIPTA%20inhaler.)

## Indication

<a id="trelegy-approval-date"></a>

### When was Trelegy Ellipta first approved in the US?

> “Initial U.S. Approval: 2017”

Source: [TRELEGY ELLIPTA: Prescribing information, page 1, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Trelegy_Ellipta/pdf/TRELEGY-ELLIPTA-PI-PIL-IFU.PDF#page=1)

## Related pages
- [Medical information: Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder): All indications](https://www.evicenter.com/medical-information/trelegy-ellipta)
- [Pharmacology](https://www.evicenter.com/medical-information/trelegy-ellipta/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/trelegy-ellipta/safety)
- [Specific populations](https://www.evicenter.com/medical-information/trelegy-ellipta/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/trelegy-ellipta/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/trelegy-ellipta/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/trelegy-ellipta/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/trelegy-ellipta/access-and-coverage)
